Population carrier screening for spinal muscular atrophy: A position statement of the association for molecular pathology

Journal of Molecular Diagnostics

Volumn 13, Issue 1, 2011, Pages 3-6

  Muralidharan, Kasinathan ^a,b   Wilson, Robert B ^a,c   Ogino, Shuji ^a,d   Nagan, Narasimhan ^a,e   Curtis, Christine ^a,f   Schrijver, Iris ^a,g  

^a Association for Molecular Pathology   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e GENZYME CORPORATION   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL RECESSIVE DISORDER; ETHNICITY; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; SHORT SURVEY; SPINAL MUSCULAR ATROPHY;

EID: 78651109303     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2010.11.012     Document Type: Short Survey

References (14)

1. Ogino S and Wilson RB: Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev Mol Diagn 2004, 111:477-500
2. Prior TW: Perspective and diagnostic considerations in spinal muscular atrophy. Genet Med 2010, 12:145-152
3. Lunn MR, Wang CH: Spinal muscular atrophy. Lancet 2008, 371:220-233
4. Prior TW: Carrier screening for spinal muscular atrophy. Gen Med 2008, 10:840-842
5. Ogino S, Wilson RB, Gold B: New insights into the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations. Eur J Hum Genet 2004, 12:1015-1023
6. Mailman MD, Heinz JW, Papp AC, Snyder PJ, Sedra MS, Wirth B, Burghes AH, Prior TW: Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002, 4:20-26 (Pubitemid 44698460)
7. Wirth B, Schmidt T, Hahnen E, Rudnik-Schöneborn S, Krawczak M, Müller-Myhsok B, Schönling J, Zerres K: De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet 1997, 61:1102-1111
8. Wilson RB, Ogino S: Carrier frequency of spinal muscular atrophy. Lancet 2008, 1:1542
9. Committee on Genetics: ACOG Committee opinion No. 432: spinal muscular atrophy. Obstet Gynec 2009, 5:1194-1196
10. Horvath AR: Grading quality of evidence and strength of recommendations for diagnostics tests and strategies. Clin Chem 2009, 55:853-855
11. Prior TW, Snyder PJ, Rink BD, Pearl DK, Pyatt RE, Mihal DC, Conlan T, Schmalz B, Montgomery L, Ziegler K, Noonan C, Hashimoto S, Garner S: Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet A 2010, 152A:1608-1616
12. Hendrickson BC, Donohoe C, Akmaev VR, Sugarman EA, Labrousse P, Boguslavskiy L, Flynn K, Rohlfs EM, Walker A, Allitto B, Sears C, Scholl T: Differences in SMN1 allele frequencies among ethnic groups within North America. J Med Genet 2009, 46:641-644
13. Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, Burghes AH, Kissel JT: A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 2009, 85:408-413
14. Ogino S, Wilson RB: Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum Genet 2002, 111:477-500 (Pubitemid 36075081)